| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 07/12/2000 | EP1017382A1 Biarylalkanoic acids as cell adhesion inhibitors |
| 07/12/2000 | EP1017378A1 Amide derivatives for the treatment of diseases mediated by cytokines |
| 07/12/2000 | CN1259951A Novel pharmaceutically useful compounds |
| 07/12/2000 | CN1259940A Crystalline roxifiban |
| 07/12/2000 | CN1259522A Novel protain from lobar pneumonia Actinomyces |
| 07/12/2000 | CN1259360A Medicine for treating pulmonary hart diseases |
| 07/12/2000 | CN1259343A Air pressed package using polyoxyethylene glyceryl oleate |
| 07/12/2000 | CN1259342A Air pressed package using polyoxyethylene glyceryl oleate |
| 07/12/2000 | CN1054374C New (thia) cycloalkyl [b] indole compounds process for the prepn. thereof and pharmaceutical compositions containing them |
| 07/12/2000 | CN1054373C Full fluoralkyl-substituted bezoylguanidine prepn. pharmaceutical use of same and pharmaceutical containing same |
| 07/12/2000 | CN1054282C Stabilized medicinal aerosol solution formulations |
| 07/11/2000 | US6087392 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 07/11/2000 | US6087381 Pyrazole derivatives as p38 kinase inhibitors |
| 07/11/2000 | US6087368 Quinazolinone inhibitors of cGMP phosphodiesterase |
| 07/11/2000 | US6087360 Method of treating heart failure with endothelin antagonists |
| 07/11/2000 | US6087351 Method for reducing adenosine levels with a dehydroepiandrosterone and optionally a ubiquinone |
| 07/11/2000 | US6087330 Process to inhibit binding of the integrin α4 β1 to VCAM-1 or fibronectin and cyclic peptides therefor |
| 07/11/2000 | US6086898 Administering listeria adjuvants and antigens for immunology |
| 07/11/2000 | CA2023340C (quinolin-2-ylmethoxy) indoles as inhibitors of the biosynthesis of leukotrienes |
| 07/06/2000 | WO2000039311A1 Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 |
| 07/06/2000 | WO2000039308A1 Ikk3 kinase |
| 07/06/2000 | WO2000039299A2 Streptococcus antigens |
| 07/06/2000 | WO2000039279A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 07/06/2000 | WO2000039275A2 Multiple shear stress responsive elements (ssre) and methods of use thereof |
| 07/06/2000 | WO2000039157A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/06/2000 | WO2000039126A1 Method for preparing (r)- (+) -3 {1- [2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl]- 4-phenylpiperidin -4-yl}-1,1- dimethylurea, its salts solvates and/or hydrates |
| 07/06/2000 | WO2000039125A1 Piperidines as ccr5 modulators |
| 07/06/2000 | WO2000039116A1 Aminopyrazole derivatives |
| 07/06/2000 | WO2000039114A2 Substituted oximes and hydrazones as neurokinin antagonists |
| 07/06/2000 | WO2000039103A1 Dihydro-benzo(1,4)oxazines and tetrahydroquinoxalines |
| 07/06/2000 | WO2000039096A1 2-methylimidazoline compounds |
| 07/06/2000 | WO2000039091A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 07/06/2000 | WO2000038786A2 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO2000038785A2 Methods for treating certain diseases using naaladase inhibitors |
| 07/06/2000 | WO2000038737A2 GENE THERAPY FOR PULMONARY EDEMA USING ADENOVIRUS VECTORS ENCODING Na,K-ATPase |
| 07/06/2000 | WO2000038733A1 Peptidic product, process and composition |
| 07/06/2000 | WO2000038730A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia |
| 07/06/2000 | WO2000038719A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | WO2000038718A2 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia |
| 07/06/2000 | WO2000038717A2 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 07/06/2000 | WO2000038715A2 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 07/06/2000 | WO2000038692A1 Cystic fibrosis remedies containing vitamin d3 derivatives |
| 07/06/2000 | WO2000038684A1 (2-imidazolin-2-ylamino) quinoxaline derivatives for the treatment of pain |
| 07/06/2000 | WO2000038680A1 Azabicycloalkanes as ccr5 modulators |
| 07/06/2000 | WO2000038676A1 Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors |
| 07/06/2000 | WO2000038674A1 COMPOUNDS WHICH AFFECT mRNA STABILITY AND USES THEREFOR |
| 07/06/2000 | WO2000038665A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO2000038660A2 Use of bisphosphonates for the prevention and treatment of infectious processes |
| 07/06/2000 | WO2000038653A1 Improved formulation for topical non-invasive application in vivo |
| 07/06/2000 | WO2000021512A3 Composition and method for treating allergic diseases |
| 07/06/2000 | WO2000018429A3 Vaccine based on attenuated $i(haemophilus somnus) |
| 07/06/2000 | WO2000017222A8 31 human secreted proteins |
| 07/06/2000 | WO2000015770A3 Human serine/threonine protein kinases |
| 07/06/2000 | WO2000014222A3 Gabab receptor subtypes gabab-r1c and gabab-r2 and heterodimers thereof |
| 07/06/2000 | WO2000013703A3 Methods of treating hypertension and compositions for use therein |
| 07/06/2000 | WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 07/06/2000 | WO1999052514A3 Pharmaceutical composition and combination preparation for immunosuppressive therapy |
| 07/06/2000 | WO1999041282A8 Therapeutic uses of keratinocyte growth factor-2 |
| 07/06/2000 | CA2358687A1 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 07/06/2000 | CA2358094A1 Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 |
| 07/06/2000 | CA2358067A1 (2-imidazolin-2-ylamino) quinoxaline derivatives for the treatment of pain |
| 07/06/2000 | CA2356929A1 Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combonation therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356877A1 Gene therapy for pulmonary edema using adenovirus vectors encoding na,k-atpase |
| 07/06/2000 | CA2356748A1 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356622A1 Compounds which affect mrna stability and uses therefor |
| 07/06/2000 | CA2356606A1 Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356462A1 Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356459A1 Method of using a matrix metalloproteinase inhibitor and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356402A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | CA2356302A1 Method of using a cyclooxygenase-2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356262A1 Use of bisphosphonates for the prevention and treatment of infectious processes |
| 07/06/2000 | CA2356057A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/06/2000 | CA2354052A1 Methods for treating certain diseases using naaladase inhibitors |
| 07/06/2000 | CA2351539A1 Method for preparing (r)- (+) -3 {1- ¬2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl|- 4-phenylpiperidin -4-yl}-1,1- dimethylurea, its salts solvates and/or hydrates |
| 07/06/2000 | CA2351357A1 Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors |
| 07/06/2000 | CA2350589A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 07/05/2000 | EP1016415A2 Use of a fibrin glue for the regeneration of tissue |
| 07/05/2000 | EP1015604A1 Human prl-1 phosphatase |
| 07/05/2000 | EP1015566A1 Human ste20-like stress activated serine/threonine kinase |
| 07/05/2000 | EP1015493A1 Novel epithelial tissue targeting agent |
| 07/05/2000 | EP1015492A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 07/05/2000 | EP1015464A2 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE |
| 07/05/2000 | EP1015458A1 Furopyrrolidine derivatives and their use as serine protease inhibitors |
| 07/05/2000 | EP1015456A1 Pyrrolopyrrolidine derivatives and their use as serine protease inhibitors |
| 07/05/2000 | EP1015455A1 Pyrrolopyrrolone derivatives |
| 07/05/2000 | EP1015454A1 Method of inhibiting serine protease enzymes |
| 07/05/2000 | EP1015443A1 Thromboxane ligands |
| 07/05/2000 | EP1015437A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals |
| 07/05/2000 | EP1015431A1 2-aminopyridines as inhibitors of cyclooxygenase-2 |
| 07/05/2000 | EP1015421A1 New phenylamidine derivatives, a process for preparing the same and their use as medicaments |
| 07/05/2000 | EP1014993A1 New use for budesonide and formoterol |
| 07/05/2000 | EP1014983A1 Naproxen/cetirizine compositions and methods for treating respiratory disorders |
| 07/05/2000 | EP1014981A1 Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime |
| 07/05/2000 | EP1014976A1 Novel substituted imidazole compounds |
| 07/05/2000 | EP1014972A1 Method of treatment and pharmaceutical composion |
| 07/05/2000 | EP1014960A1 Use of a specific antagonist of 5ht2 receptors for preparing medicines useful for treating sleep-disordered breathing |
| 07/05/2000 | EP1014955A1 New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising terbutaline sulphate, a process for preparing the formulation and the use thereof |
| 07/05/2000 | EP1014812A1 Smoking products containing antioxidants |
| 07/05/2000 | EP0788490B1 Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
| 07/05/2000 | EP0734381B1 Morpholine tachykinin receptor antagonists |